YMAB

Y-MABS THERAPEUTICS INC

Healthcare | Small Cap

-$0.13

EPS Forecast

$26.35

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon
MCRBSeres Therapeutics IncARVNArvinas IncCMRXChimerix IncPTGXProtagonist Therapeutics IncRVNCRevance Therapeutics IncTGTXTg Therapeutics Inc